Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1995
10/04/1995EP0674636A1 Quinuclidine derivatives as squalene synthase inhibitors
10/04/1995EP0674635A1 Quinuclidine derivatives as squalene synthase inhibitors
10/04/1995EP0674634A1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties
10/04/1995EP0674633A1 Benzopyran derivatives
10/04/1995EP0674632A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors
10/04/1995EP0674631A1 Substituted pyrazoles as crf antagonists
10/04/1995EP0674630A1 7-HALO- AND 7$g(b),8$g(b)-METHANO-TAXOLS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
10/04/1995EP0674628A1 New chemopreventive compounds and a preparation method and use thereof
10/04/1995EP0674627A1 Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
10/04/1995EP0674626A1 Novel selective aromatase inhibiting compounds
10/04/1995EP0674625A1 Amino-substituted pyrazoles having crf antagonistic activity
10/04/1995EP0674624A1 Pyrazoles and pyrazolopyrimidines having crf antagonist activity
10/04/1995EP0674623A1 Bicyclic fibrinogen antagonists
10/04/1995EP0674622A1 Tetrahydrocarbazole derivatives as 5-ht1-like agonists
10/04/1995EP0674621A1 Enantiomers of carbazole derivatives as 5-ht1-like agonists
10/04/1995EP0674620A1 Tryptamine analogues as 5-ht 1?-like agonists
10/04/1995EP0674619A1 Tryptamine analogues as 5-ht 1?-like agonists
10/04/1995EP0674618A1 Asymmetric process for preparing florfenicol, thiamphenicol, chloramphenicol and oxazoline intermediates
10/04/1995EP0674529A1 Lipid prodrugs for oral administration
10/04/1995EP0674528A1 Cyclodextrin and polymer based drug delivery system
10/04/1995EP0674527A1 Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
10/04/1995EP0674522A1 Linseed mucilage
10/04/1995EP0674521A1 METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17$g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5$g(a)-ANDROST-1-EN-3-ONES
10/04/1995EP0674520A1 Application of carbamazepine and oxcarbazepine in the treatment of neurological lesions related to traumatic injuries
10/04/1995EP0674519A1 Potassium channel activators and use thereof in therapy
10/04/1995EP0674518A1 Application of lamotrigine in the treatment of neurological lesions related to traumatic injuries
10/04/1995EP0674517A1 Compositions containing caffeine and s(+)-ibuprofen or s(+)-flurbiprofen or s(+)-ketoprofen
10/04/1995EP0674516A1 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
10/04/1995EP0674515A1 Carbostyril derivative for inhibiting production of interleukin-8
10/04/1995EP0674514A1 Use of aryloxyalkyl substituted cyclic amines as calcium channel antagonists and new phenyloxyalkyl piperidin derivatives
10/04/1995EP0674512A1 Application of riluzole in the treatment of neurological lesions related to traumatic injuries
10/04/1995EP0674510A1 Injectable composition
10/04/1995EP0674509A1 Methods for treatment with dimercaptosuccinic acid (dmsa)
10/04/1995EP0674508A1 4-guanidinobutyramide for improving blood circulation
10/04/1995EP0674506A1 Controlled release growth hormone containing microspheres
10/04/1995EP0674505A1 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails
10/04/1995EP0618905B1 Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists
10/04/1995EP0592446B1 Loading technique for preparing drug containing liposomes
10/04/1995EP0493608B1 Quinolonecarboxylic acid derivative
10/04/1995EP0465581B1 Erythromycin derivatives
10/04/1995CN1109471A Derivative of imidazol-4yl-piperidine, preparation of same and application of same in treatment
10/04/1995CN1109469A Macrocyclic bifunctional chelants, complexes threof and their antibody conjugates
10/04/1995CN1109468A Sulfonamido heterocyclic thrombin inhibitors
10/04/1995CN1109343A High efficiency sterilizing ointment for women
10/04/1995CN1109333A Composite fuguiqin hydrochloride capsule
10/04/1995CN1109332A New use of benzo|g¨quinolines
10/04/1995CN1109331A Methods of inhibiting obsessive-compulsive and consumptive disorders
10/04/1995CN1109330A Methods of inhibiting imperfect tissue repair
10/04/1995CN1109329A Preparation for beta-carotene or carotene micro capsule and its application thereof
10/04/1995CN1109328A Sustained release formulations for 24 hour release of metoprolol
10/04/1995CN1109326A Fuguiqin hydrochloride injection
10/03/1995US5455354 Contacting ether-substituted starting material with aluminum chloride, hydrobromic acid or boron tribromide followed by tartaric acid to form hydroxy compound, contacting with carbonyldimidazole in presence of acid, reacting with amine
10/03/1995US5455348 Anticoagulants
10/03/1995US5455335 Glycosylated steroids
10/03/1995US5455280 Treatment of chronic lymphocytic leukemia with beta-carotene
10/03/1995US5455279 Regimen method of mediating neuronal damage using nitroglycerine
10/03/1995US5455277 Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
10/03/1995US5455276 Administering 2-phenylethylamine and a monoamine oxidase B inhibitor to humans
10/03/1995US5455275 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
10/03/1995US5455274 Leukotriene antagonists; treating rheumatoid arthritis
10/03/1995US5455273 N,N-disubstituted arylcycloalkylamines, the salts thereof, pharmaceutical compositions containing these compounds and the use thereof and processes for preparing them
10/03/1995US5455272 Free radical-scavenging antioxidant; cytoprotective agents, antiischemic agents
10/03/1995US5455270 Stabilized solutions of platinum(II) antitumor agents
10/03/1995US5455269 Synergistic compositions of amiodarone and beta blockers
10/03/1995US5455268 Treating arthropathy
10/03/1995US5455266 Enhanced chemotherapeutic compositions against microbial infections in fish, the preparation and use thereof
10/03/1995US5455265 For mammals; skin disorders, cancer, inflammatory disease, cardiovascular diorders, autoimmune diseases and others
10/03/1995US5455259 Compounds for the treatment of neurodegenerative disorders
10/03/1995US5455258 Useful as inhibitors of matrix-degrading metalloproteinase enzymes such as stromelysin and/or collegenase
10/03/1995US5455257 Lacidipine for the treatment of arteriosclerosis
10/03/1995US5455254 Substituted benzofuranylpiperidine as a nootropic agent
10/03/1995US5455252 Optionally substituted 6,8-quinolines
10/03/1995US5455251 Michellamine antiviral agents, compositions, and treatment methods
10/03/1995US5455250 Treating central nervous system disorders
10/03/1995US5455247 Methods for the treatment of hyperlipidemia using azaspiranes
10/03/1995US5455246 Treating neuropsychiatric disorders
10/03/1995US5455243 Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets
10/03/1995US5455241 Staurosporin derivatives as enzyme inhibitors for protein kinase C and platelet-derived growth factor kinase; antitumor agents, bactericides, antigrowth agents
10/03/1995US5455240 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof
10/03/1995US5455238 Cephalosporins
10/03/1995US5455236 Stable aqueous compositions
10/03/1995US5455235 Drink containing lactosucrose and buffer; anticarcinogenic agents, enzyme inhibitors; shelf life
10/03/1995US5455233 Detectors, antiinflammatory, antilipemic agents and antitumor agents
10/03/1995US5455232 Pharmaceutical preparation based on rhamnolipid
10/03/1995US5455227 Biologically active lipoprotein and its use
10/03/1995US5455168 α-glycosyl trehalose-forming enzyme
10/03/1995US5455049 Terfenadine oral powder
10/03/1995US5455047 Direct compression cholestyramine tablet and solvent-free coating therefor
10/03/1995US5455045 High dose formulations
10/03/1995US5455039 Administering a biocompatible polymer based heptarin releasing system
10/03/1995US5455038 Method of inhibiting listeria
10/03/1995US5455036 Method of using cis-urocaninic acid for topically treating psoriasis
10/03/1995US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method
10/03/1995CA2074493C Treatment of pruritis with esters and amides
10/03/1995CA2065093C Remedies for bone diseases
10/03/1995CA1337202C Cyclic amides which are leukotriene antagonists
10/03/1995CA1337201C 4,5,6,7-tetrahydroisothiazolo [4,5-c] pyridine derivatives
10/03/1995CA1337200C .beta.-carbolines, their bio-isosteric benzofuran and benzothiophene analogues having cytostatic properties
10/03/1995CA1337199C Five-membered ring systems with bonded azacyclic ring substituents
10/03/1995CA1337197C Subtituted thienoimidazole derivatives, a process for their preparation, pharmaceutical compositions containing them, and their use as inhibitors of gastric acid secretion
1 ... 6979 6980 6981 6982 6983 6984 6985 6986 6987 6988 6989 6990 6991 6992 6993 6994 6995 6996 6997 6998 6999 ... 7860